Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,847 | 427 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,837 | 193 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,042 | 56 | $0 (2024) |
| Janssen Biotech, Inc. | $450.72 | 19 | $0 (2024) |
| Celgene Corporation | $389.92 | 24 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $315.80 | 10 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $251.08 | 13 | $0 (2023) |
| Merck Sharp & Dohme LLC | $230.88 | 12 | $0 (2024) |
| Allergan Inc. | $217.01 | 9 | $0 (2018) |
| Intuitive Surgical, Inc. | $193.03 | 1 | $0 (2021) |
| Daiichi Sankyo Inc. | $191.89 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,003 | 40 | ABBVIE INC. ($554.46) |
| 2023 | $1,008 | 46 | AbbVie Inc. ($434.40) |
| 2022 | $1,770 | 85 | ABBVIE INC. ($1,027) |
| 2021 | $1,424 | 67 | AbbVie Inc. ($505.80) |
| 2020 | $466.77 | 25 | AbbVie Inc. ($160.09) |
| 2019 | $650.02 | 33 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($243.44) |
| 2018 | $704.24 | 47 | AbbVie, Inc. ($356.17) |
| 2017 | $1,822 | 84 | AbbVie, Inc. ($563.50) |
All Payment Transactions
427 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/28/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: GI | ||||||
| 11/21/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: GI | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Gastroenterology | ||||||
| 10/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $103.03 | General |
| Category: Immunology | ||||||
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/03/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | CREON (Drug), VIBERZI | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/13/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Rare Disease | ||||||
| 07/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Immunology | ||||||
| 06/27/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/30/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/21/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Immunology | ||||||
| 05/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 772 | 992 | $661,392 | $104,275 |
| 2022 | 14 | 813 | 1,129 | $751,377 | $116,951 |
| 2021 | 14 | 754 | 1,088 | $702,683 | $114,295 |
| 2020 | 14 | 681 | 1,073 | $619,125 | $100,696 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 177 | $109,563 | $17,907 | 16.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 76 | 77 | $90,860 | $16,997 | 18.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 71 | 143 | $79,794 | $14,487 | 18.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 169 | $62,699 | $11,200 | 17.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $52,866 | $8,771 | 16.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 47 | $40,608 | $6,729 | 16.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 43 | $35,002 | $6,043 | 17.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 68 | 68 | $43,928 | $5,027 | 11.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 78 | 78 | $72,852 | $4,878 | 6.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 38 | $23,142 | $4,007 | 17.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $18,990 | $3,162 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 31 | $13,609 | $2,256 | 16.6% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 25 | 25 | $10,975 | $1,821 | 16.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $6,504 | $990.70 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 217 | $134,974 | $21,794 | 16.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 69 | 190 | $91,010 | $16,656 | 18.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 62 | 62 | $74,524 | $13,430 | 18.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 85 | 85 | $68,425 | $10,923 | 16.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 67 | 164 | $54,612 | $10,009 | 18.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 50 | 54 | $50,004 | $8,615 | 17.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 55 | $48,015 | $7,596 | 15.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 96 | 97 | $91,859 | $7,319 | 8.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 88 | 88 | $57,640 | $6,529 | 11.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 24 | 24 | $25,536 | $4,609 | 18.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 24 | 29 | $18,299 | $3,347 | 18.3% |
About Dr. Kamyar Shahedi, M.D
Dr. Kamyar Shahedi, M.D is a Gastroenterology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2009. The National Provider Identifier (NPI) number assigned to this provider is 1780818823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kamyar Shahedi, M.D has received a total of $8,847 in payments from pharmaceutical and medical device companies, with $1,003 received in 2024. These payments were reported across 427 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($8,847).
As a Medicare-enrolled provider, Shahedi has provided services to 3,020 Medicare beneficiaries, totaling 4,282 services with total Medicare billing of $436,218. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Santa Monica, CA
- Active Since 05/04/2009
- Last Updated 08/13/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1780818823
Products in Payments
- XIFAXAN (Drug) $990.22
- LINZESS (Drug) $823.10
- HUMIRA (Biological) $541.52
- Humira (Biological) $533.88
- SKYRIZI (Biological) $530.02
- CREON (Drug) $475.49
- RINVOQ (Biological) $401.74
- ZEPOSIA (Drug) $389.92
- Creon (Drug) $287.61
- STELARA (Biological) $276.21
- Da Vinci Surgical System (Device) $193.03
- DIFICID (Drug) $192.28
- VIBERZI (Drug) $164.38
- TRULANCE (Drug) $163.57
- ENTYVIO (Biological) $162.52
- ZENPEP (Drug) $147.76
- LINX Reflux Management System (Device) $145.38
- TREMFYA (Drug) $125.27
- INJECTAFER (Drug) $120.93
- DUPIXENT (Biological) $116.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Santa Monica
Alireza Sedarat, Md, MD
Gastroenterology — Payments: $104,838
Marc Wishingrad, Md, MD
Gastroenterology — Payments: $24,677
Dr. Rudolph Bedford, M.d, M.D
Gastroenterology — Payments: $17,303
Dr. Lenna Martyak, M.d, M.D
Gastroenterology — Payments: $11,403
Claudia Sanmiguel, M.d, M.D
Gastroenterology — Payments: $6,321
Charles Frankel, M.d, M.D
Gastroenterology — Payments: $4,737